These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1002 related articles for article (PubMed ID: 28039448)

  • 41. PD-L1 Expression is Increased in Metastasizing Squamous Cell Carcinomas and Their Metastases.
    García-Díez I; Hernández-Ruiz E; Andrades E; Gimeno J; Ferrándiz-Pulido C; Yébenes M; García-Patos V; Pujol RM; Hernández-Muñoz I; Toll A
    Am J Dermatopathol; 2018 Sep; 40(9):647-654. PubMed ID: 29742559
    [TBL] [Abstract][Full Text] [Related]  

  • 42. High expression of tumor necrosis factor receptor 2 in tissue is associated with progression and prognosis of esophageal squamous cell carcinoma.
    Liu Z; Ma C; Ma G; Sun X; Liu J; Li S; Liu K; Wang J; Yang D
    Hum Pathol; 2018 Oct; 80():179-185. PubMed ID: 29920311
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Correlation of PD-L1 expression with CD8+ T cells and oxidative stress-related molecules NRF2 and NQO1 in esophageal squamous cell carcinoma.
    Zhang X; Yang Y; Zhao H; Tian Z; Cao Q; Li Y; Gu Y; Song Q; Hu X; Jin M; Jiang X
    J Pathol Clin Res; 2024 Jul; 10(4):e12390. PubMed ID: 38992928
    [TBL] [Abstract][Full Text] [Related]  

  • 44. High expression of biglycan is associated with poor prognosis in patients with esophageal squamous cell carcinoma.
    Zhu YH; Yang F; Zhang SS; Zeng TT; Xie X; Guan XY
    Int J Clin Exp Pathol; 2013; 6(11):2497-505. PubMed ID: 24228112
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Loss of PAR-3 protein expression is associated with invasion, lymph node metastasis, and poor survival in esophageal squamous cell carcinoma.
    Kitaichi T; Yasui K; Gen Y; Dohi O; Iwai N; Tomie A; Yamada N; Terasaki K; Umemura A; Nishikawa T; Yamaguchi K; Moriguchi M; Sumida Y; Mitsuyoshi H; Naito Y; Zen Y; Itoh Y
    Hum Pathol; 2017 Apr; 62():134-140. PubMed ID: 28188749
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Expression of long non-coding RNA ZEB1-AS1 in esophageal squamous cell carcinoma and its correlation with tumor progression and patient survival.
    Wang YL; Bai Y; Yao WJ; Guo L; Wang ZM
    Int J Clin Exp Pathol; 2015; 8(9):11871-6. PubMed ID: 26617942
    [TBL] [Abstract][Full Text] [Related]  

  • 47. MMP1 promotes tumor growth and metastasis in esophageal squamous cell carcinoma.
    Liu M; Hu Y; Zhang MF; Luo KJ; Xie XY; Wen J; Fu JH; Yang H
    Cancer Lett; 2016 Jul; 377(1):97-104. PubMed ID: 27130665
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Downregulation of microRNA-382 is associated with poor outcome of esophageal squamous cell carcinoma.
    Qi B; Lu JG; Yao WJ; Chang TM; Qin XG; Ji YH; Wang TY; Liu SG; Li HC; Liu YZ; Zhao BS
    World J Gastroenterol; 2015 Jun; 21(22):6884-91. PubMed ID: 26078564
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Association of p53 expression with prognosis in patients with esophageal squamous cell carcinoma.
    Yao W; Qin X; Qi B; Lu J; Guo L; Liu F; Liu S; Zhao B
    Int J Clin Exp Pathol; 2014; 7(10):7158-63. PubMed ID: 25400812
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinicopathology significance of podoplanin immunoreactivity in esophageal squamous cell carcinoma.
    Ma W; Wang K; Yang S; Wang J; Tan B; Bai B; Wang N; Jia Y; Jia M; Cheng Y
    Int J Clin Exp Pathol; 2014; 7(5):2361-71. PubMed ID: 24966946
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The prognostic value of B7-H6 in esophageal squamous cell carcinoma.
    Zhou H; Dong J; Guo L; Wang X; Wang K; Cai X; Yang S
    Sci Rep; 2019 Dec; 9(1):18122. PubMed ID: 31792298
    [TBL] [Abstract][Full Text] [Related]  

  • 52. DJ-1 could predict worse prognosis in esophageal squamous cell carcinoma.
    Yuen HF; Chan YP; Law S; Srivastava G; El-Tanani M; Mak TW; Chan KW
    Cancer Epidemiol Biomarkers Prev; 2008 Dec; 17(12):3593-602. PubMed ID: 19064576
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Loss of CRNN expression is associated with advanced tumor stage and poor survival in patients with esophageal squamous cell carcinoma.
    Hsu PK; Kao HL; Chen HY; Yen CC; Wu YC; Hsu WH; Chou TY
    J Thorac Cardiovasc Surg; 2014 May; 147(5):1612-1618.e4. PubMed ID: 24263008
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prognostic value of programmed death-ligand 1 (PD-L1) expression in ovarian clear cell carcinoma.
    Zhu J; Wen H; Bi R; Wu Y; Wu X
    J Gynecol Oncol; 2017 Nov; 28(6):e77. PubMed ID: 29027395
    [TBL] [Abstract][Full Text] [Related]  

  • 55. HOXB7 predicts poor clinical outcome in patients with advanced esophageal squamous cell cancer.
    Long QY; Zhou J; Zhang XL; Cao JH
    Asian Pac J Cancer Prev; 2014; 15(4):1563-6. PubMed ID: 24641368
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The concentration of programmed cell death-ligand 1 in the peripheral blood is a useful biomarker for esophageal squamous cell carcinoma.
    Akutsu Y; Murakami K; Kano M; Toyozumi T; Matsumoto Y; Takahashi M; Otsuka R; Sekino N; Yokoyama M; Shiraishi T; Matsubara H
    Esophagus; 2018 Apr; 15(2):103-108. PubMed ID: 29892935
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Correlation between Vascular Endothelial Growth Factor C Expressior and Lymph Node Micrometastasis and Prognosis in Patients with pNO Esophageal Squamous Cell Carcinomas.
    Sun ZG; Liu XY; Zhang M; Wang Z
    Hepatogastroenterology; 2014 May; 61(131):671-7. PubMed ID: 26176055
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prognostic Significance of Programmed Cell Death Ligand 1 (PD-L1), CD8+ Tumor-Infiltrating Lymphocytes and p53 in Non-Small Cell Lung Cancer: An Immunohistochemical Study.
    Rashed HE; Abdelrahman AE; Abdelgawad M; Balata S; Shabrawy ME
    Turk Patoloji Derg; 2017; 1(1):211-222. PubMed ID: 28832075
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Expression and prognostic value of FOXP1 in esophageal squamous cell carcinoma.
    Wei Q; Li X; Zhu Z; Yu W; Qin G; Chen H; Gu Y; Zhao K; Fu X; Sun M
    Pathol Res Pract; 2019 Dec; 215(12):152645. PubMed ID: 31704154
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Tumor PD-L1 expression, immune cell correlates and PD-1+ lymphocytes in sentinel lymph node melanoma metastases.
    Kakavand H; Vilain RE; Wilmott JS; Burke H; Yearley JH; Thompson JF; Hersey P; Long GV; Scolyer RA
    Mod Pathol; 2015 Dec; 28(12):1535-44. PubMed ID: 26403784
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 51.